Combined Recanalization Therapy for Acute Large Vessel Occlusion Stroke
ConditionStroke
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorTianjin Huanhu Hospital
About this trial
The purpose of this clinical trial is to evaluate the efficacy and safety of combined recanalization therapy in patients who cannot be recanalized by acute large vessel occlusive stroke. The main questions it aims to answer are:
1、Proportion of subjects with mRs score of 0-1 at 90 days after surgery
Participants will:
1、In acute large vessel occlusive stroke, if traditional means cannot be recanalized, combined recanalization surgery (including arteriotomy and thrombectomy, cerebrovascular bypass surgery) is performed.
Eligibility criteria
Qualifiers
Age: 18-75.
According to the current guidelines, there is a MT indication.
Before stroke, mRS ≤2;
ASPECTS ≥6;
Disqualifiers
Comorbid hemorrhagic vascular disease such as intracranial aneurysm or vascular malformation or other planned cerebrovascular surgery that may alter cerebral hemodynamics or lead to stroke;
unstable angina or myocardial infarction, congestive heart failure within the previous 6 months;
Pregnancy or perinatal period;
Hematologic disorders resulting in coagulation disorders;
Trial design
Treatments tested in this trial
- Surgery
Treatment groups
64 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov